1.91
-0.01(-0.52%)
Currency In USD
| Previous Close | 1.92 |
| Open | 1.91 |
| Day High | 1.91 |
| Day Low | 1.86 |
| 52-Week High | 2.44 |
| 52-Week Low | 1.62 |
| Volume | 107,215 |
| Average Volume | 155,467 |
| Market Cap | 107.44M |
| PE | -1.4 |
| EPS | -1.36 |
| Moving Average 50 Days | 1.92 |
| Moving Average 200 Days | 2.05 |
| Change | -0.01 |
If you invested $1000 in Seer, Inc. (SEER) since IPO date, it would be worth $33.83 as of January 16, 2026 at a share price of $1.91. Whereas If you bought $1000 worth of Seer, Inc. (SEER) shares 5 years ago, it would be worth $22.8 as of January 16, 2026 at a share price of $1.91.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Nature Genetics Study Validates Seer’s Proteograph Platform as Essential for Turning Genetic Signals Into Reliable Drug Targets and Biomarkers
GlobeNewswire Inc.
Dec 01, 2025 12:00 PM GMT
Large-scale GWAS across ~1,600 samples shows how peptide-level mass spectrometry distinguishes true protein changes from potential binding artifacts resulting from affinity-based approaches, establishing accuracy as the foundation for downstream disc
Seer and Collaborators Unveil Broad New Data Demonstrating the Translational Power of Deep Proteomics at HUPO 2025
GlobeNewswire Inc.
Nov 07, 2025 12:00 PM GMT
Studies spanning cardiovascular, aging, and cancer biology highlight how Seer’s Proteograph® platform is enabling discovery at population scaleREDWOOD CITY, Calif., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and truste
Seer Reports Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Nov 06, 2025 9:05 PM GMT
REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today reported financial results for the third quarter ended September 30, 2025. Recent Highli